Skip to main content
FSCDR Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Livestream Session
Livestream Session
Meal
Meal
On Demand
On Demand
Back
On Demand Video

Quality Improvement

A Pilot Study to Increase Naloxone Education and Prescriptions in Sickle Cell Clinics

Sunday, June 9, 2024
3:15 PM – 3:30 PM ET
Location: Grand Ballroom C
On Demand

    Presenting Author(s)

  • BM

    Brenda Merriweather, DNP, RN (she/her/hers)

    Nursing Professional Development Specialist
    Boston Medical Center
    The University of Alabama at Birmingham
    Boston, Massachusetts, United States

    Slides

    • Co-Author(s)

  • Barbara J. Speller-Brown, DNP, MSN, PNP-BC

    Lead Sickle Cell Translational Research APN, Director SCD Transition Clinic
    Children’s National Hospital, George Washington University
    George Washington University Department of Pediatric Heath Sciences
    Washington, District of Columbia, United States

  • AC

    Andrew D. Campbell, MD (he/him/his)

    Director, Comprehensive Sickle Cell Center
    Children’s National Hospital, George Washington University
    George Washington University School of Medicine and Health Sciences
    washington, District of Columbia, United States

Disclosure(s):
Brenda Merriweather, DNP, RN: No financial relationships to disclose
Andrew D. Campbell, MD: GBT / Pfizer: Research Grant (Ongoing)

Learning Objectives:

  • Upon completion of this presentation, the learner will be able to: Describe the aim of the study
  • Upon completion of this presentation, the learner will be able to: Describe the benefit of using naloxone with opioids
  • Upon completion of this presentation, the learner will be able to: Describe the positive outcomes and clinical implications of the study.